Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iron Tracer Ultrasound for Sentinel Lymph Nodes in Breast Cancer
NCT02610920Phase 1Withdrawn
- Sponsor
- Columbia University
- Start
- Dec 2015
- Primary completion
- Jun 2017
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of iron sucrose in breast cancer and ductal carcinoma in situ (DCIS), sponsored by Columbia University. Primary endpoint: Success rate of core needle biopsy of sentinel lymph node at 7 days. Planned start Dec 2015; status: withdrawn.
02
Drugs
iron sucrose
03
Conditions
breast cancerductal carcinoma in situ (DCIS)
Beyond the preview
Go deeper on NCT02610920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02610920.